A Phase I Open Label Study of Panobinostat in combination with Lenalidomide, Bortezomib, and Dexamethasone in patients with relapsed and relapsed/refractory Multiple Myeloma
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Dana-Farber/Partners CancerCare, Inc.
Start Date
June 5, 2014
End Date
October 17, 2023
Administered By
Duke Cancer Institute
Awarded By
Dana-Farber/Partners CancerCare, Inc.
Start Date
June 5, 2014
End Date
October 17, 2023